Tuesday, June 21, 2016

BRIEF-Progenics Pharmaceuticals signs commercial license agreement with Selexis SA

* Under agreement, progenics will have use of Selexis CHO-M

cell line and sure technology platform

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)